Ceterix Announces U.S. Launch of Novel Device for Minimally Invasive Orthopaedic Procedures

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif.--(BUSINESS WIRE)--Ceterix Orthopaedics™, Inc. today announced commercial availability of the company’s NovoStitch™ suture passer in the United States. The company’s device enables surgeons to place stitches in tight joint compartments, including those in knees, hips and shoulders, during minimally invasive arthroscopic surgical procedures.

Help employers find you! Check out all the jobs and post your resume.

Back to news